{
  "id": 9161458,
  "title": "This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month",
  "url": "https://urgent.news/2026/09/22/this-glp-1-drug-helped-people-maintain-their-weight-loss-in-a-9161458",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-22T15:46:00.000Z",
  "source": {
    "name": "MarketWatch Top",
    "slug": "marketwatch-top",
    "url": "https://www.marketwatch.com/story/this-glp-1-drug-helped-people-maintain-their-weight-loss-in-a-clinical-trial-even-for-those-taking-it-once-a-month-f70929b5?mod=mw_rss_topstories"
  },
  "original_language": "en",
  "account": null,
  "summary": "Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock is soaring.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "MarketWatch",
        "title": "This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month",
        "url": "https://urgent.news/2026/09/22/this-glp-1-drug-helped-people-maintain-their-weight-loss-in-a",
        "published": "2026-09-22T15:46:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}